Foster & Motley’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-804
| Closed | -$260K | – | 392 |
|
|
2025
Q3 | $260K | Sell |
804
-30
| -4% | -$9.33K | 0.01% | 362 |
|
|
2025
Q2 | $324K | Sell |
834
-22
| -3% | -$8.85K | 0.02% | 334 |
|
|
2025
Q1 | $372K | Buy |
856
+19
| +2% | +$7.63K | 0.02% | 310 |
|
|
2024
Q4 | $309K | Sell |
837
-429
| -34% | -$180K | 0.02% | 331 |
|
|
2024
Q3 | $658K | Sell |
1,266
-162
| -11% | -$86.5K | 0.04% | 249 |
|
|
2024
Q2 | $774K | Sell |
1,428
-314
| -18% | -$166K | 0.05% | 227 |
|
|
2024
Q1 | $903K | Sell |
1,742
-254
| -13% | -$126K | 0.06% | 215 |
|
|
2023
Q4 | $941K | Sell |
1,996
-84
| -4% | -$38.8K | 0.07% | 202 |
|
|
2023
Q3 | $906K | Sell |
2,080
-88
| -4% | -$39.9K | 0.07% | 204 |
|
|
2023
Q2 | $963K | Sell |
2,168
-155
| -7% | -$71.5K | 0.07% | 224 |
|
|
2023
Q1 | $1.07M | Sell |
2,323
-27
| -1% | -$12.8K | 0.09% | 214 |
|
|
2022
Q4 | $1.21M | Sell |
2,350
-64
| -3% | -$32.5K | 0.1% | 195 |
|
|
2022
Q3 | $1.1M | Sell |
2,414
-17
| -0.7% | -$8.13K | 0.1% | 189 |
|
|
2022
Q2 | $1.17M | Sell |
2,431
-56
| -2% | -$27.7K | 0.1% | 183 |
|
|
2022
Q1 | $1.22M | Sell |
2,487
-239
| -9% | -$109K | 0.1% | 182 |
|
|
2021
Q4 | $1.26M | Sell |
2,726
-71
| -3% | -$29.9K | 0.1% | 170 |
|
|
2021
Q3 | $1.04M | Sell |
2,797
-76
| -3% | -$28.9K | 0.09% | 183 |
|
|
2021
Q2 | $1.1M | Sell |
2,873
-85
| -3% | -$32.5K | 0.09% | 177 |
|
|
2021
Q1 | $1.06M | Sell |
2,958
-69
| -2% | -$22.2K | 0.09% | 174 |
|
|
2020
Q4 | $972K | Sell |
3,027
-187
| -6% | -$57.4K | 0.09% | 173 |
|
|
2020
Q3 | $863K | Sell |
3,214
-20
| -0.6% | -$5.38K | 0.1% | 163 |
|
|
2020
Q2 | $851K | Sell |
3,234
-63
| -2% | -$16.8K | 0.11% | 158 |
|
|
2020
Q1 | $749K | Sell |
3,297
-21
| -0.6% | -$5.72K | 0.11% | 154 |
|
|
2019
Q4 | $1M | Sell |
3,318
-214
| -6% | -$58.9K | 0.13% | 140 |
|
|
2019
Q3 | $848K | Sell |
3,532
-111
| -3% | -$30.4K | 0.12% | 151 |
|
|
2019
Q2 | $1.03M | Sell |
3,643
-19
| -0.5% | -$5.19K | 0.14% | 137 |
|
|
2019
Q1 | $1.05M | Sell |
3,662
-34
| -0.9% | -$9.83K | 0.15% | 131 |
|
|
2018
Q4 | $971K | Sell |
3,696
-351
| -9% | -$96.5K | 0.16% | 128 |
|
|
2018
Q3 | $1.11M | Sell |
4,047
-283
| -7% | -$73.5K | 0.17% | 116 |
|
|
2018
Q2 | $1.03M | Buy |
4,330
+745
| +21% | +$173K | 0.16% | 119 |
|
|
2018
Q1 | $788K | Buy |
3,585
+666
| +23% | +$156K | 0.13% | 138 |
|
|
2017
Q4 | $657K | Buy |
2,919
+885
| +44% | +$188K | 0.11% | 145 |
|
|
2017
Q3 | $386K | Buy |
+2,034
| New | +$387K | 0.07% | 160 |
|
Other funds holding ELV
Foster & Motley's ELV Position: Q4 2025 in Review
Foster & Motley sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 804 shares — an estimated $260K sold.
Foster & Motley first reported a position in ELV in Q3 2017 and held it in 33 quarters. The position peaked at $1.26M in Q4 2021. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.
- Foster & Motley reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
- Foster & Motley sold 804 Elevance Health shares in Q4 2025, an estimated $260K.
- Foster & Motley first reported a position in Elevance Health in Q3 2017 and held it in 33 quarters.
- Foster & Motley's Elevance Health position peaked at $1.26M in Q4 2021.
- 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.
Based on Foster & Motley's 13F filing for Q4 2025, filed 15 Jan 2026.